Institute for International Research

Scientific Advisory Committee

• Laurie Donahue-Hjelle, Ph.D., Director of Cell Line Development, Invitrogen Corporation
• Stefanos Grammatikos, Ph.D., Director Upstream Development, Biopharmaceutical Process Science, Boehringer Ingelheim Pharma GmbH & Co. KG, Germany
• John Joly, Ph.D., Director of Early Stage Cell Culture, Process Development, Genentech, Inc.
• Kevin J. Kayser, Ph.D., Research and Development Manager, Cell Line Engineering, SAFC Biosciences
• Dennis M. Kraichely, Ph.D., Principal Research Scientist, Expression Technologies, Centocor, Inc.
• Mark D. Moody, Ph.D., Senior Director, Quality Control/Formulation, Merrimack Pharmaceuticals, Inc.
• John Mott, Ph.D., Director, Bioprocess R&D, Cell Line Development, Pfizer Global Biologics
• Bernhard O. Palsson, Ph.D., Professor of Bioengineering, University of California, San Diego
• Morris Rosenberg, D.Sc., Senior Vice President, Development, Seattle Genetics

Distinguished Faculty

• Ashraf Amanullah, Ph.D., Genentech, Inc.
• Robert Babb, Ph.D., Regeneron Pharmaceuticals, Inc.
• Ben Bowen, Ph.D., Biolog
• Michael Butler, Ph.D., University of Manitoba, Canada
• Frank Carr, Ph.D., Antitope Ltd, United Kingdom
• Trevor Collingwood, Sangamo BioSciences Inc.
• Kevin Cox, MS, Biolex Therapeutics
• Keith A. Davis, Ph.D., Pfizer Inc
• Alan J. Dickson, Ph.D., University of Manchester, United Kingdom
• Laurie Donahue-Hjelle, Ph.D., Invitrogen Corporation
• Yves Durocher, Ph.D., National Research Council of Canada
• Sybille S. Galosy, Ph.D., Pfizer Inc
• Philip D. Gregory, Ph.D., Sangamo BioSciences Inc.
• Christopher Hatfield, Eli Lilly and Company
• Diane Hatton, Ph.D., MedImmune Limited, United Kingdom
• David James, University of Sheffield, United Kingdom
• Roy Jefferis, Ph.D., University of Birmingham, United Kingdom
• Nigel Jenkins, University College Dublin, Ireland
• John Joly, Ph.D., Genentech, Inc.
• Britta Krampe, Ph.D. Student, University College Dublin, Ireland
• Viswanatham Katta, Genentech, Inc.
• Randal J. Kaufmann, Ph.D., University of Michigan Medical Center
• Kevin J. Kayser, Ph.D., SAFC Biosciences
• Dennis M. Kraichely, Ph.D., Centocor, Inc.
• Deborah Lee Dormady Letham, Ph.D., Charles River Laboratories
• Gyun Min Lee, KAIST, Korea
• Peggy Lio, Invitrogen Corporation
• Paula Meleady, Ph.D., Dublin City University, Ireland
• Mark Melville, Ph.D., Wyeth BioPharma
• Michael Milburn, Ph.D., Metabolon
• John Mott, Ph.D., Pfizer Global Biologics
• Nels Pederson, Ph.D., Biogen Idec
• Genova Richardson, SAFC Biosciences
• Morris Rosenberg, D.Sc., Seattle Genetics
• Richard Schoenfeld, Ph.D., BioWorks Consulting
• Torsten W. Schulz, Ph.D., Boehringer Ingelheim Pharma GmbH & Co. KG, Germany
• Amy Shen, Genentech, Inc.
• Jose Varghese, Merrimack Pharmaceuticals
• Andy Walker, Ph.D., ICOS Biologics
• Stefan Wildt, Ph.D., Merck & Co., Inc.
• Jianguo Yang, Ph.D., MedImmune, Inc.
• Lin Zhang, Pfizer Inc